- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06316375
STUMBL Score as a Risk Stratification Tool for Management of Blunt Chest Trauma Patients
Assessment Of STUMBL Score (STUdy of the Management of BLunt Chest Wall Trauma) As A Risk Stratification Tool In Management Of Blunt Chest Trauma Patients In Emergency Departments: A Multicenter Study
Study Overview
Status
Conditions
Detailed Description
The STUMBL Score (STUdy of the Management of BLunt chest wall trauma) (also referred to as the Battle score) is a clinical prediction model that was developed and externally validated in 2014 in the UK . The purpose of the model is to assist in the clinical decision-making of patients with blunt chest wall trauma (excluding those with life-threatening injuries) in the Emergency Department (ED), through the calculation of a percentage risk of complications which in turn, provides a recommended discharge disposition. The STUMBL score includes five predictors: age at attendance, number of rib fractures, chronic lung disease, use of pre-injury anticoagulants and oxygen saturation (SpO2). This is the first score to introduce clinical variables, specifically chronic lung disease and anticoagulation, in contrast to other scores which have used anatomical variables and age alone. A huge benefit of the STUMBL score is that these variables are all routinely measured in the ED. Whilst other scores exist, the STUMBL Score is the only externally validated model with excellent predictive capabilities, that can be used for adult patients of all ages with blunt chest trauma presenting to the ED, not just a specific age group or severity of injury.
Collected data will be analyzed and tabulated by using appropriate statistical methods.
Statistical analysis will be performed by the SPSS statistical software computer program version 20 (Statistical Package for Social Science), Medcalc v.11.6.and Open Epi V.3.01.
Data will be described using mean ± standard deviation (SD) and frequencies according if they are quantitative or qualitative respectively.
Parametric tests will be used in the current study if data proved to be normally distributed.
For all statistical tests, a P value less than 0.05 will be taken to indicate a significant difference.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Hadeer Youssef, Mbbch
- Phone Number: +20 01155101663
- Email: Hadeermahmoudsy@yahoo.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The present study will be conducted on patients of blunt chest trauma of both genders "without intently selected certain gender" and had 18 years old or more.
Exclusion Criteria:
- patients <18 years of age
- patients with life threatening conditions
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary outcome was to assess the validity of the STUMBL score for all complications of chest blunt trauma, originally defined by the STUMBL authors
Time Frame: 7 days
|
These complications include:
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary outcomes validated the STUMBL score using a composite of early and delayed complications.
Time Frame: 72 hours
|
Early complications:
Delayed complications:
|
72 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUMBL blunt chest trauma
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blunt Injury of Thorax
-
University Hospital, MahdiaCompleted
-
North Memorial Health CareCompletedBlunt Injury of Thorax | Multiple Rib Fractures, Involving Three RibsUnited States
-
Unity Health TorontoSunnybrook Health Sciences Centre; Alberta Health services; The Ottawa Hospital; Hamilton Health Sciences Corporation and other collaboratorsActive, not recruitingFlail Chest | Rib Fracture | Blunt Injury of Thorax | Chest Wall Injury TraumaCanada
-
Ain Shams UniversityCompleted
-
Chang Gung Memorial HospitalCompleted
-
Wake Forest University Health SciencesRosalind Franklin University of Medicine and ScienceCompletedTrauma | Blunt Trauma | Blunt Injury | Accident | Multiorgan InjuryUnited States
-
Hôpital CochinCompletedCOPD | Malignant Neoplasm of ThoraxFrance
-
Assiut UniversityNot yet recruitingNovel STAR Score in Prediction of Intra-Abdominal Injury in Adult Blunt Abdominal Trauma Patients
-
Methodist Health SystemActive, not recruiting